Search results for "Pandemics."

showing 10 items of 483 documents

Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: a web-based survey

2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)pandemic has severely limited the clinical activity of most hospitals around the world. A previous survey of the Italian Association for the Study of the Liver (AISF) has demonstrated a negative impact of the first pandemic wave on all inpatient and outpatient hepatologyactivities. Like other countries, Italy has subsequently experienced a second and third wave, which occurred in November 2020 and in March 2021 respectively. During the second and third wave many hospitals had already developed emergency management plans and improved knowledge on the management of mild-moderate COVID19 disease was available. However, it is unknown w…

2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)COVID19Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)macromolecular substancesLiver diseaseInternal medicinePandemicmedicineHumansHCCPandemicsWeb based surveyInternetHepatologybusiness.industrySARS-CoV-2Liver DiseasescirrhosisCOVID19; HCC; SARS-CoV-2; cirrhosis; liver transplantCOVID-19Hepatologymedicine.diseasecirrhosis; COVID19; HCC; liver transplant; SARS-CoV-2; Humans; Internet; Italy; Pandemics; SARS-CoV-2; COVID-19; Liver Diseasesliver transplantItalyEmergency medicinecirrhosis COVID19 HCC liver transplant SARS-CoV-2 Humans Internet Italy Pandemics SARS-CoV-2 COVID-19 Liver Diseasesbusiness
researchProduct

Comparison of Reported Deaths From COVID-19 and Increase in Total Mortality in Italy

2020

This analysis compares reported deaths from COVID-19, February 23 to April 4, 2020, and total mortality in Italy from January 12 through April 4 in the years 2015 through 2020.

2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralMEDLINE01 natural sciences03 medical and health sciencesBetacoronavirus0302 clinical medicineCOVID-19 TestingPandemicInternal MedicineResearch LetterMedicineHumans030212 general & internal medicine0101 mathematicsMortalityMortality trendsDisease NotificationPandemicsbusiness.industryClinical Laboratory TechniquesSARS-CoV-2010102 general mathematicsCOVID-19covidPublic Reporting of Healthcare DataTotal mortalityItalyDisease NotificationEmergency medicinebusinessCoronavirus InfectionsCoronavirus Infections
researchProduct

In Reply - Cardiorespiratory Fitness Attenuates the Impact of Risk Factors Associated With COVID-19 Hospitalization

2021

2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Physical fitnessMEDLINECOVID-19Cardiorespiratory fitnessGeneral MedicineHospitalizationCardiorespiratory FitnessPhysical FitnessRisk FactorsEmergency medicinePandemicmedicineHumansHealthy LifestylebusinessPandemicsLetter to the EditorMayo Clinic Proceedings
researchProduct

„Wir wussten, dass es schwierig wird, doch damit haben wir nicht gerechnet!“ Erfahrungen beim Studieneinschluss von Krebspatient*innen mit Migrations…

2021

Zusammenfassung Hintergrund Der Prozess des Studieneinschlusses von Teilnehmenden ist ein wichtiger Bestandteil und oftmals aufwendiger Arbeitsschritt in wissenschaftlichen Forschungsprojekten. Aufgrund unterschiedlicher finanzieller, organisatorischer und ethischer Rahmenbedingungen stellt die fristgerechte Gewinnung von Teilnehmenden haufig eine Herausforderung dar. In diesem Beitrag berichten wir uber unsere Erfahrungen hinsichtlich des Studieneinschlusses, die wir im Projekt „Psychoonkologische Versorgung von Krebspatienten mit Migrationshintergrund – eine Mixed-Methods-Studie“ (POM) gemacht haben. Methode Die Gewinnung von Teilnehmenden erfolgte uber ambulante hamato-onkologische Schwe…

2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Qualitative BefragungMedicine (miscellaneous)Psycho-oncologyVulnerable GruppenCovid-19 pandemicEducationCovid-19-PandemieStudy inclusionGermanyNeoplasmsPolitical sciencemedicineHumansPsychoonkologiePandemicsTransients and MigrantsGynecologyStudieneinschlussSARS-CoV-2Health PolicyQualitative interviewsVersorgungsforschung / Health Services ResearchCOVID-19Qualitative interviewVulnerable groupsZeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen
researchProduct

Impact of asymptomatic COVID-19 patients in global surgical practice during the COVID-19 pandemic

2020

The rapid spread of COVID-19 has changed the global surgical care. Patients infected with COVID-19 may present without typical symptoms, and such asymptomatic patients may potentially trigger in-hospital outbreaks by transmitting the disease to health care providers and other hospitalized patients. Further, asymptomatic COVID-19 patients have worse postop- erative outcomes with an unexpectedly high morbidity and mortality, reaching 20⋅5 per cent deaths. However, we do not have objective global data on this issue. In an attempt to clarify the current global surgical practice under the COVID-19 pandemic particularly focusing on the preoperative screening of asymptomatic COVID-19 patients, we …

2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)covid-19 pandemic surgerySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Settore MED/18 - CHIRURGIA GENERALEMEDLINECOVID-19. Global surgery.AsymptomaticCOVID-19 Critical Pathways Cross Infection Cross-Sectional Studies Health Care Surveys Humans Pandemics Postoperative Complications SARS-CoV-2 Surgical Procedures Operative Asymptomatic InfectionsCOVID-19; Critical Pathways; Cross Infection; Cross-Sectional Studies; Health Care Surveys; Humans; Pandemics; Postoperative Complications; SARS-CoV-2; Surgical Procedures Operative; Asymptomatic InfectionsNOsurgeryTumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14]Postoperative ComplicationsPandemicCorrespondencemedicineHumansPandemicsAsymptomatic InfectionsLS7_4COVIDCross InfectionSurgical ProceduresCritical pathwaysbusiness.industrySARS-CoV-2pandemicCOVID-19Surgical proceduresOperativeSettore MED/18covid 19 surgical practiceCOVID-19 - surgeryCross-Sectional StudiesSurgical Procedures OperativeHealth Care SurveysEmergency medicineCritical Pathwaysmedicine.symptombusiness
researchProduct

The UK needs a sustainable strategy for COVID-19

2020

The UK is well into the second wave of COVID-19, with 60 051 lives lost to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to date, according to provisional data from the Office for National Statistics. Official UK Government data show that cases have been rising exponentially since late August, 2020, with increases across all regions in England in recent weeks.As of Nov 4, 2020, the UK had 25 177 confirmed daily cases. These are almost certainly underestimates as between Oct 17 and Oct 23, 2020, England alone had 52 000 estimated daily cases.Estimates of the effective reproduction number in England vary between 1.1 and 1.6.Daily deaths have doubled every fortnight si…

2019-20 coronavirus outbreakmedicine.medical_specialtyEconomic growthCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)International CooperationStrategyMEDLINESDG 3 - Good Health and Well-beingPolitical sciencePandemicCorrespondencemedicineFinancial SupportHumansPandemics/prevention & controlPandemicsReino unidoSchoolsSustainable strategyCOVID-19/economicsUnited Kingdom/epidemiologyPublic healthCOVID-19General MedicineCommunicable Disease Control/methodsDelivery of Health Care/methodsUnited KingdomCommunicable Disease Control/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingPublic HealthCOVID 19Delivery of Health Care
researchProduct

Comment on “ COVID ‐19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action”

2020

2019-20 coronavirus outbreakmedicine.medical_specialtyLetterCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralDermatologyBetacoronavirusPsoriasisMedicineHumansPsoriasisLimit (mathematics)LettersLetters to the EditorPandemicsLetter to the Editorbusiness.industrySARS-CoV-2COVID-19General Medicinemedicine.diseaseDermatologyAction (philosophy)businessCoronavirus InfectionsCoronavirus InfectionsImmunosuppressive AgentsDermatologic Therapy
researchProduct

Immunosuppressive treatment for systemic sclerosis—Therapeutic challenges during the COVID ‐19 pandemic

2020

2019-20 coronavirus outbreakmedicine.medical_specialtyLetterCoronavirus disease 2019 (COVID-19)systemic sclerosisPneumonia ViralDermatologySclerodermaCOVID‐19Risk FactorsPsoriasisPandemicmedicineHumansPsoriasisLettersIntensive care medicinePandemicsImmunosuppressive treatmentbusiness.industryCOVID-19immunosuppressive treatmentGeneral Medicinemedicine.diseasePneumoniaCoronavirus InfectionsbusinessImmunosuppressive AgentsCoronavirus InfectionsDermatologic Therapy
researchProduct

In Reply – Association of Renin Angiotensin System Blockers with Outcomes in Patients With COVID-19

2020

2019-20 coronavirus outbreakmedicine.medical_specialtyhypertensionCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Renin-Angiotensin COVID-19 hypertensionCOVID-19General MedicineRenin-Angiotensin SystemBetacoronavirusInternal medicineRenin–angiotensin systemHumansMedicineIn patientCoronavirus InfectionsbusinessPandemicsRenin-AngiotensinLetter to the EditorMayo Clinic Proceedings
researchProduct

The European COVID-19 drugs calculation tool: an aid for the estimation of the drugs needed during the SARS-CoV 2 pandemic

2021

Objective To create an informatics supportive tool, which can assist healthcare professionals in estimating potential requirements for essential drug supplies to respond to the current SARS-CoV-2 pandemic based on epidemiological forecasting. Methods The tool was based on a Susceptible-Infected-Removed (SIR) epidemiological model in which the population is divided into three compartments and transmission parameters are specified to define the rate at which people move between stages. Appropriate data entry was guaranteed by the creation of structured guided paths. The drugs needed for the forecasted patients were estimated according to a list of critical care drugs compiled by consulting pr…

2474Critical CareComputer sciencePopulationPsychological intervention030226 pharmacology & pharmacyHealth informaticsHealth care rationing03 medical and health sciences0302 clinical medicinePandemicmedicineHumans030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticseducationPandemicsOriginal ResearchEstimationeducation.field_of_studyhealth care rationingSARS-CoV-2business.industrypractice guidelinepublic healthCOVID-19CLINICAL MEDICINEmedicine.disease2341Hospitalizationhealth care economics and organizationsWorkflowInformaticsMedical emergencybusinessMedical InformaticsEuropean Journal of Hospital Pharmacy
researchProduct